Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL Awards for Enterprise 2014

Publication date: Jun 27, 2013 03:49 PM

Start: May 29, 2014 06:15 PM

Location: UCL Bloomsbury Theatre

UCL Awards for Enterprise audience

The UCL Awards for Enterprise honour the efforts and accomplishments of UCL’s innovative and entrepreneurial academics and students.

The awards ceremony and reception highlight UCL as a leading hub of innovation and commercial activity, while bringing together academics with businesses and investors.

Find out more and register for the 2014 UCL Awards for Enterprise


UCL Awards for Enterprise 2013 highlights